ASPERCREME WITH LIDOCAINE PAIN RELIEVING CREME- lidocaine hydrochloride lotion 
Chattem, Inc.

----------

Aspercreme with Lidocaine Pain Relieving Creme

Drug Facts

Active ingredient

Lidocaine HCI 4%

Purpose

Topical anesthetic

Uses

temporarily relieves minor pain 

Warnings

For external use only

Do not use

  • on puncture wounds
  • on large areas of the body or on cut, irritated or swollen skin
  • for more than one week without consulting a doctor

When using this product

  • use only as directed. Read and follow all directions and warnings on this carton.
  • do not allow contact with the eyes and mucous membranes
  • do not bandage or apply local heat (such as heating pads) to the area of use
  • do not use at the same time as other topical analgesics

Stop use and ask a doctor if

  • condition worsens
  • redness is present
  • irritation develops
  • symptoms persist for more than 7 days or clear up and occur again within a few days

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children and pets.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

adults and children over 12 years:

children 12 years and younger: ask a doctor

Inactive ingredients

acrylates/C10-30 alkyl acrylate crosspolymer, alcohol denat. (15%), aloe barbadensis leaf juice, aminomethyl propanol, C30-45 alkyl cetearyl dimethicone crosspolymer, caprylyl methicone, cetearyl alcohol, ceteth-20 phosphate, dicetyl phosphate, dimethicone, disodium EDTA, ethylhexylglycerin, glyceryl stearate, methylparaben, steareth-21, water

PRINCIPAL DISPLAY PANEL

ODOR FREE
Aspercreme
WITH 4% LIDOCAINE
MAXIMUM STRENGTH
Pain Relieving CREME
Net wt 2.7 oz (76.5 g)

PRINCIPAL DISPLAY PANEL
ODOR FREE
Aspercreme
WITH 4% LIDOCAINE
MAXIMUM STRENGTH
Pain Relieving CREME
Net wt 2.7 oz (76.5 g)
 

ASPERCREME WITH LIDOCAINE PAIN RELIEVING CREME 
lidocaine hydrochloride lotion
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:41167-0582
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
LIDOCAINE HYDROCHLORIDE (UNII: V13007Z41A) (LIDOCAINE - UNII:98PI200987) LIDOCAINE HYDROCHLORIDE ANHYDROUS4 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
CARBOMER INTERPOLYMER TYPE A (55000 CPS) (UNII: 59TL3WG5CO)  
ALOE VERA LEAF (UNII: ZY81Z83H0X)  
AMINOMETHYLPROPANOL (UNII: LU49E6626Q)  
CAPRYLYL TRISILOXANE (UNII: Q95M2P1KJL)  
CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)  
CETETH-20 PHOSPHATE (UNII: 921FTA1500)  
DIHEXADECYL PHOSPHATE (UNII: 2V6E5WN99N)  
DIMETHICONE (UNII: 92RU3N3Y1O)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
STEARETH-21 (UNII: 53J3F32P58)  
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:41167-0582-51 in 1 CARTON12/01/2014
176.5 g in 1 BOTTLE; Type 0: Not a Combination Product
2NDC:41167-0582-21 in 1 CARTON12/01/2014
249.6 g in 1 TUBE; Type 0: Not a Combination Product
3NDC:41167-0582-81 in 1 CARTON12/01/201412/31/2022
3133 g in 1 BOTTLE; Type 0: Not a Combination Product
4NDC:41167-0582-42 in 1 CARTON12/01/201401/31/2021
4113 g in 1 BOTTLE; Type 0: Not a Combination Product
5NDC:41167-0582-11 in 1 CARTON11/01/2020
5121 g in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01712/01/2014
Labeler - Chattem, Inc. (003336013)

Revised: 10/2023
Document Id: 27787b51-fdf9-4ecd-bccd-ae154da024a0
Set id: d5da67c3-c2ec-4e3e-abe9-cc862dcfc8bd
Version: 10
Effective Time: 20231025
 
Chattem, Inc.